Date published: 2025-10-15

1-800-457-3801

SCBT Portrait Logo
Seach Input

DUS1L Inhibitors

DUS1L inhibitors represent a class of chemical compounds that target and inhibit the activity of the enzyme dihydrouridine synthase 1-like (DUS1L). DUS1L is an enzyme that plays a crucial role in the post-transcriptional modification of transfer RNA (tRNA), specifically in the formation of dihydrouridine, a modified nucleoside found in the D-loop of certain tRNAs. Dihydrouridine modification is important for the proper folding and function of tRNA molecules, as it contributes to the structural flexibility and stability of these essential RNA components during protein synthesis. Inhibiting DUS1L can disrupt the modification process, leading to alterations in tRNA structure and function, which in turn can affect the overall protein synthesis machinery within the cell. This disruption can have significant downstream effects on cellular processes, particularly those that are dependent on the efficient and accurate translation of genetic information into functional proteins. The chemical structures of DUS1L inhibitors are diverse, reflecting the complexity of their target and the need for specific interactions with the enzyme's active site. These inhibitors typically act by binding to the catalytic site of DUS1L, where they can either mimic the natural substrates or interfere with the enzyme's ability to carry out its catalytic function. The binding affinity and specificity of these inhibitors are crucial factors that determine their effectiveness in modulating DUS1L activity. Structural studies of DUS1L inhibitors have revealed various binding modes, often involving hydrogen bonding, hydrophobic interactions, and sometimes metal coordination, depending on the inhibitor's chemical composition. Understanding these interactions at a molecular level provides insight into the mechanism of DUS1L inhibition and guides the design and optimization of more potent inhibitors. As research continues, new DUS1L inhibitors are being identified and characterized, offering a deeper understanding of the role of DUS1L in cellular biology and the potential consequences of its inhibition.

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$66.00
$219.00
$417.00
97
(3)

Wortmannin can inhibit phosphoinositide 3-kinases (PI3K), which indirectly affects downstream signaling pathways possibly associated with DUS1L activity regulation.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$62.00
$155.00
$320.00
233
(4)

Rapamycin can inhibit mTOR, a kinase involved in cell growth and proliferation, potentially affecting DUS1L-related processes.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

LY294002 is another PI3K inhibitor, thereby able to alter signaling pathways that could intersect with DUS1L function.

Triciribine

35943-35-2sc-200661
sc-200661A
1 mg
5 mg
$102.00
$138.00
14
(1)

Triciribine can inhibit AKT activation, which might be part of a cascade involving DUS1L.

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$63.00
$241.00
136
(2)

U0126 can inhibit MEK, which is upstream of ERK in the MAPK pathway, potentially influencing DUS1L-related signaling.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$88.00
$342.00
284
(5)

SB203580 can inhibit p38 MAP kinase, another regulator that can affect pathways associated with DUS1L.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

SP600125 can inhibit JNK, thereby modulating stress response pathways that could intersect with DUS1L.

Brefeldin A

20350-15-6sc-200861C
sc-200861
sc-200861A
sc-200861B
1 mg
5 mg
25 mg
100 mg
$30.00
$52.00
$122.00
$367.00
25
(3)

Brefeldin A can disrupt the Golgi apparatus function, potentially affecting the localization and function of proteins like DUS1L.

Cycloheximide

66-81-9sc-3508B
sc-3508
sc-3508A
100 mg
1 g
5 g
$40.00
$82.00
$256.00
127
(5)

Cycloheximide can inhibit protein synthesis, thereby indirectly affecting the levels and function of DUS1L.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$39.00
$90.00
212
(2)

PD98059 can inhibit MEK, which is involved in the MAPK pathway, potentially altering signaling related to DUS1L.